106 related articles for article (PubMed ID: 38814201)
1. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
3. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
[TBL] [Abstract][Full Text] [Related]
5. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
Yu J; Zhu C; Yin J; Yu D; Wan F; Tang X; Jiang X
Drug Des Devel Ther; 2020; 14():361-370. PubMed ID: 32095070
[TBL] [Abstract][Full Text] [Related]
7. TRPC6 and FSGS: the latest TRP channelopathy.
Mukerji N; Damodaran TV; Winn MP
Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
[TBL] [Abstract][Full Text] [Related]
8. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
9. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
[TBL] [Abstract][Full Text] [Related]
11. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
13. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol.
Anderson M; Kim EY; Hagmann H; Benzing T; Dryer SE
Am J Physiol Cell Physiol; 2013 Aug; 305(3):C276-89. PubMed ID: 23657570
[TBL] [Abstract][Full Text] [Related]
15. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
[TBL] [Abstract][Full Text] [Related]
16. R168H and V165X mutant podocin might induce different degrees of podocyte injury via different molecular mechanisms.
Fan Q; Zhang H; Ding J; Liu S; Miao J; Xing Y; Yu Z; Guan N
Genes Cells; 2009 Sep; 14(9):1079-90. PubMed ID: 19674119
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation-dependent activation of TRPC6 regulated by PLC-γ1 and nephrin: effect of mutations associated with focal segmental glomerulosclerosis.
Kanda S; Harita Y; Shibagaki Y; Sekine T; Igarashi T; Inoue T; Hattori S
Mol Biol Cell; 2011 Jun; 22(11):1824-35. PubMed ID: 21471003
[TBL] [Abstract][Full Text] [Related]
18. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
Chiluiza D; Krishna S; Schumacher VA; Schlöndorff J
J Biol Chem; 2013 Jun; 288(25):18407-20. PubMed ID: 23645677
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
20. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
Roshanravan H; Dryer SE
Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]